表纸
市场调查报告书

先进球囊导管的全球市场:2021-2030

Global Advanced Balloon Catheter Market: Analysis and Forecast, 2021-2030

出版商 BIS Research Inc. 商品编码 969676
出版日期 内容资讯 英文 283 Pages
商品交期: 最快1-2个工作天内
价格
先进球囊导管的全球市场:2021-2030 Global Advanced Balloon Catheter Market: Analysis and Forecast, 2021-2030
出版日期: 2020年11月03日内容资讯: 英文 283 Pages
简介

由于新的冠状病毒感染(COVID-19)的影响,先进的球囊导管的全球市场目前显示出逐渐收缩的趋势。然而,在预测期内,它将保持6.25%的复合年增长率,并预计到2030年将增长到44.530亿美元。由于COVID-19大流行而终止的选择性手术对市场产生了负面影响,但预计这种影响是短期的。诸如心血管疾病和周围动脉疾病的流行,对微创外科手术的需求增加,气囊导管的发展以及发达国家的有利的报销条件等因素预计将推动市场的增长。

本报告调查了先进球囊导管的全球市场,定义和概述了市场,分析了COVID-19和其他市场影响因素,法律和法规环境,赎回环境,专利分析以及市场规模趋势。汇总了预测,产品类型/应用/组件/患者群体/最终用户/地区/主要国家等,按类别分类的细分,竞争环境,主要公司的概况等。

目录

执行摘要

第1章产品定义

第2章调查范围

第3章调查方法

第4章COVID-19的影响

第5章流行病学/救赎情况

  • 使用球囊导管
  • 兑换情况:按地区

第6章工业分析

  • 产业结构
  • 供应链分析
  • 协会/财团
  • 监管框架:按地区
  • 专利分析

第7章竞争情况

  • 市场份额分析
  • 主要发展/战略
  • 产品流水线分析
  • 常规类型和高级类型的比较
  • 价格分析

第8章全球市场规模/预测

  • 前提条件/约束
  • 评估主要调查结果/机会
  • 市场动态
    • 增长动力
    • 生长抑制剂
    • 影响分析
    • 市场机会

第9章市场分析/预测:按产品类型

  • 概述
  • 普通球囊导管
  • 切割和划痕球囊导管
  • 药物涂层球囊导管
  • 覆膜支架球囊导管

第10章市场分析/预测:按应用

  • 概述
  • 冠状动脉手术
  • 周边手术
  • 神经血管外科
  • 其他

第11章市场分析/预测:按组成部分

  • 概述
  • 快速交换(Rx)球囊导管
  • 钢丝(OTW)球囊导管
  • 固定丝球囊导管

第12章市场分析/预测:按患者分组

  • 概述
  • 成人
  • 儿童

第13章市场分析/预测:按最终用户

  • 概述
  • 医院/门诊手术中心
  • 导管实验室
  • 其他

第14章市场分析/预测:按地区/主要国家/地区

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第15章公司简介

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Biotronik AG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Cook Group
  • Hexacath
  • Koninklijke Philips N.V.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • OrbusNeich Medical
  • Terumo Corporation
目录
Product Code: BHM0859SA

"Global Advanced Balloon Catheter Market to Reach $4,405.3 Million by 2030."

Market Report Coverage - Advanced Balloon Catheter

Market Segmentation

  • Product Type- Normal Balloon Catheter, Cutting and Scoring balloon catheter, Drug-Coated balloon catheter, and Stent Graft balloon catheter
  • Application- Coronary procedures, Peripheral procedures, Neurovascular procedures, and Others
  • Component- Over the Wire balloon catheter, Rapid Exchange balloon catheter, and Fixed-Wire balloon catheter
  • Patient age- Adult and Pediatric
  • End-User- Hospitals and Ambulatory Surgery Centers, Catherization Laboratories, and Others

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, Rest-of-Europe
  • Asia-Pacific - China, Japan, India, South Korea, Singapore, Australia and New Zealand, Rest-of-Asia-Pacific
  • Latin America- Brazil, Mexico, and Rest of Latin America
  • Middle East and Africa

Growth Drivers

  • Increasing prevalence of cardiovascular and peripheral artery disease
  • Increasing demand for minimally invasive surgery
  • Advancement in balloon catheter
  • Favorable reimbursement landscape in developed economies

Market Challenges

  • High cost of angioplasty
  • Risk and complication associated with catheterization procedures

Market Opportunities

  • Development of novel drug-coated balloon catheter
  • Development of multipurpose balloon catheter

Key Companies Profiled

Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Koninklijke Philips N.V., Medtronic plc, MicroPort Scientific Corporation, Terumo Corporation, Biotronik AG, Cardionovum GmbH, Concept Medical Inc., Cook Group, Hexacath, and OrbusNeich Medical

Key Questions Answered in this Report:

  • How has the COVID-19 pandemic impacted the global advanced balloon catheter market?
  • What is the adoption rate of the balloon catheters in peripheral artery disease (PAD) and coronary artery disease (CAD) across various regions?
  • What is the reimbursement landscape for the balloon catheters across various regions?
  • How does the regulatory landscape for the balloon catheters impact the overall global advanced balloon catheter market?
  • Who are the key players in the global advanced balloon catheters and their respective market share?
  • What are the key strategies employed by the companies for entering the market between 2016-June 2020?
  • What is the patent landscape for the global advanced balloon catheter market? Who are the major market players that have filed for patents between January 2017- August 2020?
  • How will the entry of products that are in the pipeline till mid-September 2020 impact the global advanced balloon catheter market during the forecast period 2021-2030?
  • What are the various types of balloon catheters available in the global advanced balloon catheter market? What is their market share in 2019 and 2030, respectively?
  • Which type of balloon catheter is anticipated to witness the growth with the highest compound annual growth rate (CAGR) during the forecast period 2021-2030?
  • What are the emerging applications for the balloon catheters?
  • What are the various components of balloon catheters? Which type of balloon catheter is anticipated to witness significant growth during the forecast period 2021-2030?
  • How is the global advanced balloon catheter market anticipated to grow in the emerging economies, such as Asia-Pacific, Latin America, Middle East, and Africa?

Market Overview

The global advanced balloon catheter market is witnessing a moderate decline in the size of the market due to the ongoing COVID-19 pandemic. The overall market was estimated to be $2,523.9 million in FY2019, and it is expected to grow at a CAGR of 6.25% during the forecast period, 2021-2030. Presently, more than 70 companies are operating in this market, including already existing and emerging medical device companies.

Owing to the COVID-19 pandemic, the global elective surgeries were shutdown, which, in turn, caused the decline of the global advanced balloon catheter market in 2020. However, the impact of the pandemic is anticipated to be short-term, and with the resumption of elective procedures, the global advanced balloon catheter market is projected to recover from 2021.

Our healthcare experts are continuously analyzing the impact of the industrial and regulatory decisions on the global advanced balloon catheter market. The market is driven by certain factors, increasing prevalence of cardiovascular and peripheral artery diseases, increasing demand for minimally invasive surgeries, advancements in the balloon catheters, and favorable reimbursement landscape in developed economies.

The market is favored by the development of novel drug-coated balloon catheter and multipurpose balloon catheter.

Within the research report, the market is segmented based on product type, component, application, patient age, end-user, and regional analysis. Each of these segments covers the market's snapshot over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Table of Contents

Executive Summary

1 Product Definition

2 Scope of Report

  • 2.1 Scope of Study
  • 2.2 Exclusion Criteria of the Report
  • 2.3 Key Questions Answered by the Research Study

3 Research Methodology

  • 3.1 Primary Data Sources
  • 3.2 Secondary Data Sources
  • 3.3 Data Sources Categorization
  • 3.4 Selection Criteria for Company Profiles
  • 3.5 Brief Overview of the Market Estimation Process
  • 3.6 Data Validation
  • 3.7 Assumptions and Limitations

4 Impact of COVID-19 on Global Advanced Balloon Catheter Market

  • 4.1 Impact on Patients
  • 4.2 Impact on Adoption Rate of Advanced Balloon Catheters
  • 4.3 Impact on the Growth Rate of the Global Advanced Balloon Catheter Market
  • 4.4 Entry Barriers and Opportunities for Companies Entering Global Advanced Balloon Catheter Market

5 Epidemiology and Reimbursement Landscape for Global Advanced Balloon Catheter Market

  • 5.1 Utilization of Balloon Catheters
    • 5.1.1 Coronary Procedures
    • 5.1.2 Peripheral Procedures
  • 5.2 Reimbursement Landscape
    • 5.2.1 The U.S.
    • 5.2.2 Europe

6 Industry Analysis

  • 6.1 Industry Structure
    • 6.1.1 Balloon Catheters Manufacturers
    • 6.1.2 Distributors
  • 6.2 Industry Supply Chain Analysis
    • 6.2.1 Raw Material
    • 6.2.2 Impact of COVID-19 on Supply Chain
  • 6.3 Associations and Consortiums
  • 6.4 Regulatory Framework
    • 6.4.1 Regulatory Framework in North America
      • 6.4.1.1 Food and Drug Administration (FDA)
      • 6.4.1.2 Health Canada
    • 6.4.2 Regulatory Framework in Europe
    • 6.4.3 Regulatory Framework in Asia-Pacific
      • 6.4.3.1 National Medical Products Administration (NMPA)
      • 6.4.3.2 Pharmaceutical and Medical Device Agency (PMDA)
      • 6.4.3.3 Central Drug Standard Control Organization (CDSCO)
  • 6.5 Patent Analysis
    • 6.5.1 Patent Analysis (by Product)
    • 6.5.2 Patent Analysis (by Country)

7 Competitive Landscape

  • 7.1 Market Share Analysis
  • 7.2 Key Developments and Strategies
    • 7.2.1 Regulatory and Legal
    • 7.2.2 Mergers and Acquisitions
    • 7.2.3 Partnerships, Alliances, and Business Expansions
    • 7.2.4 New Offerings
    • 7.2.5 Funding Activities
  • 7.3 Product Pipeline Analysis
  • 7.4 Comparison Between Conventional Balloon Catheters and Advanced Balloon Catheters
  • 7.5 Pricing Analysis

8 Global Advanced Balloon Catheter Market Sizing and Forecast

  • 8.1 Assumptions and Limitations
  • 8.2 Key Findings and Opportunity Assessment
    • 8.2.1 Key Findings
    • 8.2.2 Opportunity Assessment
  • 8.3 Market Dynamics
    • 8.3.1 Market Drivers
      • 8.3.1.1 Increasing Prevalence of Cardiovascular and Peripheral Artery Diseases
      • 8.3.1.2 Increasing Demand for Minimally Invasive Surgeries
      • 8.3.1.3 Advancements in Balloon Catheters
      • 8.3.1.4 Favorable Reimbursement Landscape in Developed Economies
    • 8.3.2 Market Restraints
      • 8.3.2.1 Risk and Complications Associated with Catherization Procedures
      • 8.3.2.2 High Cost of Angioplasty Procedures
    • 8.3.3 Impact Analysis
    • 8.3.4 Market Opportunities
      • 8.3.4.1 Development of Novel Drug-Coated Balloon Catheters
      • 8.3.4.2 Development of Multipurpose Advanced Balloon Catheter

9 Global Advanced Balloon Catheter Market (by Product Type)

  • 9.1 Overview
  • 9.2 Normal Balloon Catheter
  • 9.3 Cutting and Scoring Balloon Catheter
  • 9.4 Drug-Coated Balloon Catheter
  • 9.5 Stent Graft Balloon Catheter

10 Global Advanced Balloon Catheter Market (by Application)

  • 10.1 Overview
  • 10.2 Coronary Procedures
  • 10.3 Peripheral Procedures
  • 10.4 Neurovascular Procedures
  • 10.5 Other Procedures

11 Global Advanced Balloon Catheter Market (by Component)

  • 11.1 Overview
  • 11.2 Rapid Exchange (Rx) Balloon Catheter
  • 11.3 Over the Wire (OTW) Balloon Catheter
  • 11.4 Fixed Wire Balloon Catheter

12 Global Advanced Balloon Catheter Market (by Patient Age)

  • 12.1 Overview
  • 12.2 Adult
  • 12.3 Pediatric

13 Global Advanced Balloon Catheter Market (by End User)

  • 13.1 Overview
  • 13.2 Hospitals and Ambulatory Surgery Centers
  • 13.3 Catheterization Laboratories
  • 13.4 Others

14 Global Advanced Balloon Catheter Market (by Region)

  • 14.1 North America Advanced Balloon Catheter Market
    • 14.1.1 North America Advanced Balloon Catheter Market (by Product Type)
    • 14.1.2 North America Advanced Balloon Catheter Market (by Application)
    • 14.1.3 North America Advanced Balloon Catheter Market (by Patient Age)
    • 14.1.4 North America Advanced Balloon Catheter Market (by End User)
    • 14.1.5 North America Advanced Balloon Catheter Market (by Country)
      • 14.1.5.1 The U.S.
        • 14.1.5.1.1 The U.S. Advanced Balloon Catheter Market (by End User)
      • 14.1.5.2 Canada
        • 14.1.5.2.1 Canada Advanced Balloon Catheter Market (by End User)
  • 14.2 Europe Advanced Balloon Catheter Market
    • 14.2.1 Europe Advanced Balloon Catheter Market (by Product Type)
    • 14.2.2 Europe Advanced Balloon Catheter Market (by Application)
    • 14.2.3 Europe Advanced Balloon Catheter Market (by Patient Age)
    • 14.2.4 Europe Advanced Balloon Catheter Market (by End User)
    • 14.2.5 Europe Advanced Balloon Catheter Market (by Country)
      • 14.2.5.1 Germany
        • 14.2.5.1.1 Germany Advanced Balloon Catheter Market (by End User)
      • 14.2.5.2 The U.K.
        • 14.2.5.2.1 The U.K. Advanced Balloon Catheter Market (by End User)
      • 14.2.5.3 France
        • 14.2.5.3.1 France Advanced Balloon Catheter Market (by End User)
      • 14.2.5.4 Italy
        • 14.2.5.4.1 Italy Advanced Balloon Catheter Market (by End User)
      • 14.2.5.5 Spain
        • 14.2.5.5.1 Spain Advanced Balloon Catheter Market (by End User)
      • 14.2.5.6 Rest-of-Europe
        • 14.2.5.6.1 Rest-of-Europe Advanced Balloon Catheter Market (by End User)
  • 14.3 Asia-Pacific Advanced Balloon Catheter Market
    • 14.3.1 Asia-Pacific Advanced Balloon Catheter Market (by Product Type)
    • 14.3.2 Asia-Pacific Advanced Balloon Catheter Market (by Application)
    • 14.3.3 Asia-Pacific Advanced Balloon Catheter Market (by Patient Age)
    • 14.3.4 Asia-Pacific Advanced Balloon Catheter Market (by End User)
    • 14.3.5 Asia-Pacific Advanced Balloon Catheter Market (by Country)
      • 14.3.5.1 Japan
        • 14.3.5.1.1 Japan Advanced Balloon Catheter Market (by End User)
      • 14.3.5.2 China
        • 14.3.5.2.1 China Advanced Balloon Catheter Market (by End User)
      • 14.3.5.3 India
        • 14.3.5.3.1 India Advanced Balloon Catheter Market (by End User)
      • 14.3.5.4 South Korea
        • 14.3.5.4.1 South Korea Advanced Balloon Catheter Market (by End User)
      • 14.3.5.5 Australia and New Zealand
        • 14.3.5.5.1 Australia and New Zealand Advanced Balloon Catheter Market (by End User)
      • 14.3.5.6 Singapore
        • 14.3.5.6.1 Singapore Advanced Balloon Catheter Market (by End User)
      • 14.3.5.7 Rest-of-Asia-Pacific
        • 14.3.5.7.1 Rest-of-Asia-Pacific Advanced Balloon Catheter Market (by End User)
  • 14.4 Latin America Advanced Balloon Catheter Market
    • 14.4.1 Latin America Advanced Balloon Catheter Market (by Product Type)
    • 14.4.2 Latin America Advanced Balloon Catheter Market (by Application)
    • 14.4.3 Latin America Advanced Balloon Catheter Market (by Patient Age)
    • 14.4.4 Latin America Advanced Balloon Catheter Market (by End User)
    • 14.4.5 Latin America Advanced Balloon Catheter Market (by Country)
      • 14.4.5.1 Brazil
        • 14.4.5.1.1 Brazil Advanced Balloon Catheter Market (by End User)
      • 14.4.5.2 Mexico
        • 14.4.5.2.1 Mexico Advanced Balloon Catheter Market (by End User)
      • 14.4.5.3 Rest-of-Latin America
        • 14.4.5.3.1 Rest-of-Latin America Advanced Balloon Catheter Market (by End User)
  • 14.5 Middle East and Africa Advanced Balloon Catheter Market
    • 14.5.1 Middle East and Africa Advanced Balloon Catheter Market (by Product Type)
    • 14.5.2 Middle East and Africa Advanced Balloon Catheter Market (by Application)
    • 14.5.3 Middle East and Africa Advanced Balloon Catheter Market (by Patient Age)
    • 14.5.4 Middle East and Africa Advanced Balloon Catheter Market (by End User)

15 Company Profiles

  • 15.1 Abbott Laboratories
    • 15.1.1 Company Overview
    • 15.1.2 Role of Abbott Laboratories in Global Advanced Balloon Catheter Market
    • 15.1.3 Financials
    • 15.1.4 Recent Developments
    • 15.1.5 SWOT Analysis
  • 15.2 B. Braun Melsungen AG
    • 15.2.1 Company Overview
    • 15.2.2 Role of B. Braun Melsungen AG. in Global Advanced Balloon Catheter Market
    • 15.2.3 Financials
    • 15.2.4 Recent Developments
    • 15.2.5 SWOT Analysis
  • 15.3 Becton Dickinson and Company
    • 15.3.1 Company Overview
    • 15.3.2 Role of Becton, Dickinson and Company in Global Advanced Balloon Catheter Market
    • 15.3.3 Financials
    • 15.3.4 Recent Developments
    • 15.3.5 SWOT Analysis
  • 15.4 Biotronik AG
    • 15.4.1 Company Overview
    • 15.4.2 Role of Biotronik AG in Global Advanced Balloon Catheter Market
    • 15.4.3 SWOT Analysis
  • 15.5 Boston Scientific Corporation
    • 15.5.1 Company Overview
    • 15.5.2 Role of Boston Scientific Corporation in the Advanced Balloon Catheter Market
    • 15.5.3 Financials
    • 15.5.4 SWOT Analysis
  • 15.6 Cardinal Health, Inc.
    • 15.6.1 Company Overview
    • 15.6.2 Role of Cardinal Health, Inc. in Global Advanced Balloon Catheter
    • 15.6.3 Financials
    • 15.6.4 Recent Developments
    • 15.6.5 SWOT Analysis
  • 15.7 Cardionovum GmbH
    • 15.7.1 Company Overview
    • 15.7.2 Role of Cardionovum GmbH in Global Advanced Balloon Catheter
    • 15.7.3 Recent Developments
    • 15.7.4 SWOT Analysis
  • 15.8 Concept Medical Inc.
    • 15.8.1 Company Overview
    • 15.8.2 Role of Concept Medical Inc. in Global Advanced Balloon Catheter
    • 15.8.3 Recent Developments
    • 15.8.4 SWOT Analysis
  • 15.9 Cook Group
    • 15.9.1 Company Overview
    • 15.9.2 Role of Cook Group in Global Advanced Balloon Catheter Market
    • 15.9.3 Recent Developments
    • 15.9.4 SWOT Analysis
  • 15.1 Hexacath
    • 15.10.1 Company Overview
    • 15.10.2 Role of Hexacath in Global Advanced Balloon Catheter Market
    • 15.10.3 SWOT Analysis
  • 15.11 Koninklijke Philips N.V.
    • 15.11.1 Company Overview
    • 15.11.2 Role of Koninklijke Philips N.V. in Global Advanced Balloon Catheter Market
    • 15.11.3 Financials
    • 15.11.4 Recent Developments
    • 15.11.5 SWOT Analysis
  • 15.12 Medtronic plc
    • 15.12.1 Company Overview
    • 15.12.2 Role of Medtronic plc in Global Advanced Balloon Catheter Market
    • 15.12.3 Financials
    • 15.12.4 Recent Developments
    • 15.12.5 SWOT Analysis
  • 15.13 MicroPort Scientific Corporation
    • 15.13.1 Company Overview
    • 15.13.2 Role of MicroPort Scientific Corporation in Global Advanced Balloon Catheter Market
    • 15.13.3 Financials
    • 15.13.4 Recent Developments
    • 15.13.5 SWOT Analysis
  • 15.14 OrbusNeich Medical
    • 15.14.1 Company Overview
    • 15.14.2 Role of OrbusNeich Medical in Global Advanced Balloon Catheter Market
    • 15.14.3 Recent Developments
    • 15.14.4 SWOT Analysis
  • 15.15 Terumo Corporation
    • 15.15.1 Company Overview
    • 15.15.2 Role of Terumo Corporation in Global Advanced Balloon Catheter Market
    • 15.15.3 Financials
    • 15.15.4 Recent Developments
    • 15.15.5 SWOT Analysis

List of Tables

  • Table 5.1: CPT Codes and the Associated Procedures
  • Table 5.2: U.S. Balloon Angioplasty Reimbursement
  • Table 5.3: Europe Normal Balloon Angioplasty Reimbursement
  • Table 5.4: Europe Drug-Coated Balloon Angioplasty Reimbursement
  • Table 6.1: Balloon Catheter Manufacturers
  • Table 6.2: Associations/Consortiums of the Global Advanced Balloon Catheter Market
  • Table 7.1: Global Advanced Balloon Catheter Market: Product Pipeline Analysis
  • Table 7.2: Average Pricing of Coronary Normal Balloon Catheters
  • Table 7.3: Average Pricing of Peripheral Normal Balloon Catheters
  • Table 7.4: Average Pricing of Cutting and Scoring Balloon Catheters
  • Table 7.5: Average Pricing of Drug-Coated Balloon Catheters
  • Table 8.1: Advanced Balloon Catheters: Indications and Products
  • Table 8.2: Cumulative Cost and QALY Analysis of CABG, PCI and Medical Treatment
  • Table 14.1: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in North America, 2015-2017
  • Table 14.2: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in the U.S., 2015-2017
  • Table 14.3: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Canada, 2015-2017
  • Table 14.4: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Europe, 2015-2017
  • Table 14.5: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Germany, 2015-2017
  • Table 14.6: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in the U.K., 2015-2017
  • Table 14.7: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in France, 2015-2017
  • Table 14.8: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Italy, 2015-2017
  • Table 14.9: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Spain, 2015-2017
  • Table 14.10: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Asia, 2015-2017
  • Table 14.11: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Japan, 2015-2017
  • Table 14.12: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in China, 2015-2017
  • Table 14.13: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in India, 2015-2017
  • Table 14.14: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in South Korea, 2015-2017
  • Table 14.15: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Australia and New Zealand, 2015-2017
  • Table 14.16: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Singapore, 2015-2017
  • Table 14.17: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Latin America, 2015-2017
  • Table 14.18: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Brazil, 2015-2017
  • Table 14.19: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Mexico, 2015-2017
  • Table 14.20: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Rest-of-Latin America, 2015-2017
  • Table 14.21: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Middle East and Africa, 2015-2017

List of Figures

  • Figure 1: Global Cost Burden Analysis for Diseases
  • Figure 2: Global Advanced Balloon Catheter Market, Pre-COVID-19, $Million
  • Figure 3: Post-COVID-19: Global Advanced Balloon Catheter Market
  • Figure 4: Impact Analysis: Global Advanced Balloon Catheter Market
  • Figure 5: Global Advanced Balloon Catheter Market: Industry Structure
  • Figure 6: Market Share Analysis of Global Advanced Balloon Catheter Market (by Company), 2019
  • Figure 7: Share of Activities in Key Developments, 2016-August 2020
  • Figure 8: Global Advanced Balloon Catheter Market (by Product Type), 2019 vs. 2030
  • Figure 9: Global Advanced Balloon Catheter Market (by Patient Age), 2019 vs. 2030
  • Figure 10: Global Advanced Balloon Catheter Market (by End User), 2019 vs. 2030
  • Figure 11: Global Advanced Balloon Catheter Market (by Region)
  • Figure 2.1: Global Advanced Balloon Catheter Market Segmentation
  • Figure 3.1: Global Advanced Balloon Catheter Market: Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Total Number of Healthcare Company Profiles
  • Figure 3.5: Assumptions and Limitations
  • Figure 4.1: COVID-19 Impact on Elective Procedures in Europe
  • Figure 4.2: Recovery of Global Advanced Balloon Catheter Market in the Post-COVID-19 Scenario
  • Figure 4.3: Global Advanced Balloon Catheter Market: Entry Barriers and Opportunities
  • Figure 5.1: Coronary Procedures (by Region), 2010-2019
  • Figure 5.2: Peripheral Procedures (by Region), 2010-2019
  • Figure 6.1: Global Advanced Balloon Catheter Market: Supply Chain Analysis
  • Figure 6.2: FDA 510(k) Approval Timeline
  • Figure 6.3: Health Canada Class IV-Medical Device Approval Process
  • Figure 6.4: European Commission Class IV-Medical Device Approval Process
  • Figure 6.5: National Medical Products Administration Class III-Medical Device Approval Process
  • Figure 6.6: Pharmaceutical and Medical Devices Agency (PMDA) Class III-Medical Device Approval Process
  • Figure 6.7: Central Drug Standard Control Organization (CDSCO) Class D-Medical Device Approval Process
  • Figure 6.8: Patent Segmentation, by Year, Country, and Product
  • Figure 6.9: Patent Segmentation, (by Product)
  • Figure 6.10: Patent Segmentation (by Country)
  • Figure 7.1: Market Share Analysis of Global Advanced Balloon Catheter Market (by Company), 2019
  • Figure 7.2: Share of Key Developments and Strategies, January 2016-Mid September 2020
  • Figure 7.3: Regulatory and Legal (by Company), January 2016-April 2020
  • Figure 7.4: Mergers and Acquisitions(by Company), January 2016- Mid September 2020
  • Figure 7.5: Partnerships, Alliances, and Business Expansions (by Company), January 2016-Mid-September 2020
  • Figure 7.6: New Offerings (by Company), January 2016-mid-September 2020
  • Figure 7.7: Funding Activities (by Company), January 2016-Mid-September 2020
  • Figure 7.8: Conventional and Advanced Balloon Catheters Market Share, 2019 vs. 2030
  • Figure 8.1: Increasing Prevalence of Cardiovascular Disease and Peripheral Artery Disease, 2010-2017
  • Figure 8.2: Global Increase in Transluminal Coronary Angioplasty, 2013-2017
  • Figure 8.3: Risk and Complications Associated with Catherization Procedures
  • Figure 8.4: Global Advanced Balloon Catheter Market: Impact Analysis
  • Figure 9.1: Global Advanced Balloon Catheter Market (by Product Type), 2019 and 2030
  • Figure 9.2: Global Advanced Balloon Catheter Market (by Normal Balloon Catheter), $Million, 2019-2030
  • Figure 9.3: Global Advanced Balloon Catheter Market (by Cutting and Scoring Balloon Catheter), $Million, 2019-2030
  • Figure 9.4: Global Advanced Balloon Catheter Market (by Drug-Coated Balloon Catheter), $Million, 2019-2030
  • Figure 9.5: Global Advanced Balloon Catheter Market (by Stent-Graft Balloon Catheter), $Million, 2019-2030
  • Figure 10.1: Global Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
  • Figure 10.2: Global Coronary Procedure in Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 10.3: Global Advanced Balloon Catheter Market (by Coronary Procedures), $Million, 2019-2030
  • Figure 10.4: Global Peripheral Procedure in Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 10.5: Global Advanced Balloon Catheter Market (by Peripheral Procedures), $Million, 2019-2030
  • Figure 10.6: Global Advanced Balloon Catheter Market (by Neurovascular Procedures), $Million, 2019-2030
  • Figure 10.7: Global Advanced Balloon Catheter Market (by Other Procedures), $Million, 2019-2030
  • Figure 11.1: Global Advanced Balloon Catheter Market (by Component), $Million, 2019-2030
  • Figure 11.2: Global Advanced Balloon Catheter Market (by Rapid Exchange Catheter), $Million, 2019-2030
  • Figure 11.3: Global Advanced Balloon Catheter Market (Over the Wire), $Million, 2019-2030
  • Figure 11.4: Global Advanced Balloon Catheter Market (Fixed-Wire Catheter), $Million, 2019-2030
  • Figure 12.1: Global Advanced Balloon Catheter Market (Adult Patient), $Million, 2019-2030
  • Figure 12.2: Global Advanced Balloon Catheter Market ( Pediatric Patient), $Million, 2019-2030
  • Figure 13.1: Global Advanced Balloon Catheter Market (by Hospitals and Ambulatory Surgery Centers), $Million, 2019-2030
  • Figure 13.2: Global Advanced Balloon Catheter Market (Catherization Laboratories), $Million, 2019-2030
  • Figure 13.3: Global Advanced Balloon Catheter Market (Academic and Research Institutes), $Million, 2019-2030
  • Figure 14.1: Global Advanced Balloon Catheter Market (by Region), 2019
  • Figure 14.2: Global Advanced Balloon Catheter Market (by Region), $Million, 2019-2030
  • Figure 14.3: North America Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.4: North America Coronary Angioplasty Volume (by Balloon Type), 2010-2019
  • Figure 14.5: North America Peripheral Artery Procedure (by Balloon Type), 2010-2019
  • Figure 14.6: North America: Market Dynamics
  • Figure 14.7: North America Advanced Balloon Catheter Market (by Product Type), $Million, 2019-2030
  • Figure 14.8: North America Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
  • Figure 14.9: North America Advanced Balloon Catheter Market (by Patient Age), $Million, 2019-2030
  • Figure 14.10: North America Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.11: North America Advanced Balloon Catheter Market (by Country)
  • Figure 14.12: U.S. Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.13: U.S. Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.14: Canada Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.15: Canada Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.16: Europe Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.17: Europe Coronary Angioplasty Volume (by Balloon Type), 2010-2019
  • Figure 14.18: Europe Peripheral Artery Angioplasty Volume (by Balloon Type), 2010-2019
  • Figure 14.19: Europe: Market Dynamics
  • Figure 14.20: Europe Advanced Balloon Catheter Market (by Product Type), $Million, 2019-2030
  • Figure 14.21: Europe Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
  • Figure 14.22: Europe Advanced Balloon Catheter Market (by Patient Age), $Million, 2019-2030
  • Figure 14.23: Europe Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.24: Europe Advanced Balloon Catheter Market (by Country)
  • Figure 14.25: Germany Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.26: Germany Advanced Balloon Catheter Market, (by End User), $Million, 2019-2030
  • Figure 14.27: U.K. Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.28: U.K. Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.29: France Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.30: France Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.31: Italy Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.32: Italy Advanced Balloon Catheter Market, (by End User), $Million, 2019-2030
  • Figure 14.33: Spain Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.34: Spain Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.35: Rest-of-Europe Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.36: Rest-of-Europe Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.37: Asia-Pacific Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.38: Asia-Pacific Coronary Angioplasty (by Balloon Type), 2010-2019
  • Figure 14.39: Asia-pacific: Market Dynamics
  • Figure 14.40: Asia-Pacific Advanced Balloon Catheter Market (by Product Type), $Million, 2019-2030
  • Figure 14.41: Asia-Pacific Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
  • Figure 14.42: Asia-Pacific Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
  • Figure 14.43: Asia-Pacific Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.44: Asia-Pacific Advanced Balloon Catheter Market (by Country)
  • Figure 14.45: Japan Advanced Balloon Catheter Market, $Million, 2021-2030
  • Figure 14.46: Japan Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.47: China Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.48: China Advanced Balloon Catheter Market, (by End User), $Million, 2019-2030
  • Figure 14.49: India Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.50: India Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.51: South Korea Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.52: South Korea Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.53: Australia and New Zealand Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.54: Australia and New Zealand Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.55: Singapore Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.56: Singapore Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.57: Rest- of-Asia-Pacific Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.58: Rest-of-Asia-Pacific Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.59: Latin America Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.60: Latin America: Market Dynamics
  • Figure 14.61: Latin America Advanced Balloon Catheter Market, (by Product Type), $Million, 2019-2030
  • Figure 14.62: Latin America Advanced Balloon Catheter Market, (by Application), $Million, 2019-2030
  • Figure 14.63: Latin America Advanced Balloon Catheter Market, (by Patient Age), $Million, 2019-2030
  • Figure 14.64: Latin America Advanced Balloon Catheter Market, (by End User), $Million, 2019-2030
  • Figure 14.65: Latin America Advanced Balloon Catheter Market (by Country), $Million, 2019-2030
  • Figure 14.66: Brazil Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.67: Brazil Advanced Balloon Catheter Market (by End User), 2019-2030
  • Figure 14.68: Mexico Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.69: Mexico Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 14.70 Rest-of-Latin America Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.71: Rest-of-Latin America Advanced Balloon Catheter Market, (by End User), $Million, 2019-2030
  • Figure 14.72: Middle East and Africa Advanced Balloon Catheter Market, $Million, 2019-2030
  • Figure 14.73: Middle East and Africa: Market Dynamics
  • Figure 14.74: Middle East and Africa Advanced Balloon Catheter Market (by Product Type), $Million, 2019-2030
  • Figure 14.75: Middle East and Africa Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
  • Figure 14.76: Middle East and Africa Advanced Balloon Catheter Market (by Patient Age), $Million, 2019-2030
  • Figure 14.77: Middle East and Africa Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
  • Figure 15.1: Abbott Laboratories: Overall Product Portfolio
  • Figure 15.2: Abbott Laboratories: Overall Financials, 2017-2019
  • Figure 15.3: Abbott Laboratories: Revenue (by Business Segment), 2017-2019
  • Figure 15.4: Abbott Laboratories: Revenue (by Region), 2017-2019
  • Figure 15.5: Abbott Laboratories.: R&D Expense, 2017-2019
  • Figure 15.6: Abbott Laboratories: SWOT Analysis
  • Figure 15.7: B. Braun Melsungen AG.: Overall Product Portfolio
  • Figure 15.8: B. Braun Melsungen AG.: Overall Financials, 2017-2019
  • Figure 15.9: B. Braun Melsungen AG. Revenue (by Business Segment), 2017-2019
  • Figure 15.10: B. Braun Melsungen AG. Revenue (by Region), 2017-2019
  • Figure 15.11: B. Braun Melsungen AG.: R&D Expense, 2017-2019
  • Figure 15.12: B. Braun Melsungen AG: SWOT Analysis
  • Figure 15.13: Becton, Dickinson And Company: Overall Product Portfolio
  • Figure 15.14: Becton, Dickinson And Company: Overall Financials, 2017-2019
  • Figure 15.15: Becton, Dickinson and Company Revenue (by Business Segment), 2017-2019
  • Figure 15.16: Becton, Dickinson and Company Revenue (by Region), 2017-2019
  • Figure 15.17: Becton, Dickinson, and Company: R&D Expense, 2017-2019
  • Figure 15.18: Becton, Dickinson And Company: SWOT Analysis
  • Figure 15.19: Biotronik AG: Overall Product Portfolio
  • Figure 15.20: Biotronik AG: SWOT Analysis
  • Figure 15.21: Boston Scientific Corporation: Overall Product Portfolio
  • Figure 15.22: Boston Scientific Corporation: Overall Financials, 2017-2019
  • Figure 15.23: Boston Scientific Corporation Revenue (by Business Segment), 2017-2019
  • Figure 15.24: Boston Scientific Corporation Revenue (by Region), 2017-2019
  • Figure 15.25: Boston Scientific Corporation: R&D Expense, 2017-2019
  • Figure 15.26: Boston Scientific Corporation: SWOT Analysis
  • Figure 15.27: Cardinal Health, Inc.: Overall Product Portfolio
  • Figure 15.28: Cardinal Health, Inc.: Overall Financials, 2017-2019
  • Figure 15.29: Cardinal Health, Inc. Revenue (by Business Segment), 2017-2019
  • Figure 15.30: Cardinal Health, Inc. Revenue (by Region), 2017-2019
  • Figure 15.31: Cardinal Health, Inc.: SWOT Analysis
  • Figure 15.32: Cardionovum GmbH: Overall Product Portfolio
  • Figure 15.33: Cardionovum GmBH: SWOT Analysis
  • Figure 15.34: Concept Medical: Overall Product Portfolio
  • Figure 15.35: Concept Medical Inc: SWOT Analysis
  • Figure 15.36: Cook Group: Overall Product Portfolio
  • Figure 15.37: Cook Group: SWOT Analysis
  • Figure 15.38: Hexacath: Overall Product Portfolio
  • Figure 15.39: Hexacath: SWOT Analysis
  • Figure 15.40: Koninklijke Philips N.V.: Overall Product Portfolio
  • Figure 15.41: Koninklijke Philips N.V.: Overall Financials: 2017-2019
  • Figure 15.42: Koninklijke Philips N.V.: Revenue (by Business Segment), 2017-2019
  • Figure 15.43: Koninklijke Philips N.V.: Revenue (by Region), 2017-2019
  • Figure 15.44: Koninklijke Philips N.V: R&D Expense, 2017-2019
  • Figure 15.45: Koninklijke Philips N.V.: SWOT Analysis
  • Figure 15.46: Medtronic plc: Overall Product Portfolio
  • Figure 15.47: Medtronic plc: Overall Financials, 2017-2019
  • Figure 15.48: Medtronic plc: Revenue (by Segment), 2017-2019
  • Figure 15.49: Medtronic plc: Revenue (by Region), 2017-2019
  • Figure 15.50: Medtronic plc: R&D Expense, 2017-2019
  • Figure 15.51: Medtronic plc: SWOT Analysis
  • Figure 15.52: MicroPort Scientific Corporation: Overall Product Portfolio
  • Figure 15.53: MicroPort Scientific Corporation: Overall Financials, 2017-2019
  • Figure 15.54: MicroPort Scientific Corporation Revenue (by Business Segment), 2017
  • Figure 15.55: MicroPort Scientific Corporation Net Revenue (by Business Segment), 2018-2019
  • Figure 15.56: MicroPort Scientific Corporation Revenue (by Region), 2017-2019
  • Figure 15.57: MicroPort Scientific Corporation: R&D Expense, 2017-2019
  • Figure 15.58: MicroPort Scientific Corporation: SWOT Analysis
  • Figure 15.59: OrbusNeich Medical: Overall Product Portfolio
  • Figure 15.60: OrbusNeich Medical.: SWOT Analysis
  • Figure 15.61: Terumo Corporation: Overall Product Portfolio
  • Figure 15.62: Terumo Corporation: Overall Financials, 2017-2019
  • Figure 15.63: Terumo Corporation Revenue (by Business Segment), 2017-2019
  • Figure 15.64: Terumo Corporation Revenue (by Region), 2017-2019
  • Figure 15.65: Terumo Corporation.: R&D Expense, 2017-2019
  • Figure 15.66: Terumo Corporation: SWOT Analysis